BioCentury
ARTICLE | Company News

Arc Pharma, University of British Columbia deal

November 24, 2003 8:00 AM UTC

ARC received an exclusive worldwide license to the university's IP covering a set of compounds to treat surgical adhesions. Under a 2002 deal, ARC received exclusive worldwide rights to another set of...